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Infection with Salmonella typhimurium has no effect on the
composition and cleavage speciﬁcity of the 20S proteasome
in human lymphoid cells
Introduction
The onset of reactive arthritis (ReA) is caused by infec-
tion with several Gram-negative bacteria, including spe-
cies of Yersinia, Campylobacter, Shigella, Chlamydia and
Salmonella. The last of these is an intracellular bacterium
that resides inside vacuoles. Salmonella typhimurium pro-
liferates inside several cell types, such as macrophages and
epithelial cells, but not in lymphoid cells.1,2 Spondylo-
arthropathies, including ReA, are strongly associated with
the class I allotype human leucocyte antigen (HLA)-B27.3
The pathogenetic role of this molecule remains unknown,
but several hypotheses have been proposed.4 Among
them, the ‘arthritogenic peptide’ model claims that HLA-
B27-restricted cytotoxic T lymphocytes (CTLs) activated
against bacterial peptides might cross-react, through
molecular mimicry, with endogenous peptides constitu-
tively presented by HLA-B27, leading to autoimmunity.5
Proteasomes are the major proteolytic system gener-
ating peptide ligands of the major histocompatibility
complex (MHC) class I molecules.6,7 They are located
in the nucleus and cytosol and are involved in degrada-
tion of cytosolic and nuclear proteins, generally follow-
ing ubiquitylation. Peptides are transported to the
endoplasmic reticulum where they bind to nascent class
I molecules. Some class I ligands can be directly gener-
ated by the proteasome8,9 but others require further
processing.10–12
The 20S proteasome is the proteasomal catalytic core.
It is a ring-barrel structure consisting of four heptameric
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Summary
Human leucocyte antigen (HLA)-B27 is strongly associated with spondylo-
arthropathies, including reactive arthritis. Several Gram-negative bacteria,
such as Salmonella typhimurium, can trigger this disease. It has been
suggested that peptides derived from bacterial proteins and presented by
HLA-B27 to cytotoxic T lymphocytes might show molecular mimicry with
autologous peptides, leading to T-cell cross-reaction and autoimmunity.
Antigen presentation in Salmonella-infected cells could be modulated by
changes in the composition of the proteasome, which is the major proteo-
lytic system that generates major histocompatibility complex class I ligands.
In this study we analysed whether the composition or activity of the 20S
proteasome was altered upon infection of lymphoid cells by S. typhimu-
rium. Two-dimensional gel electrophoresis failed to show any differences
between the composition of 20S proteasomes from cells infected with
S. typhimurium for 24 hr, relative to non-infected cells. In addition, diges-
tions of oxidized insulin B-chain with purified 20S proteasomes from non-
infected and infected cells generated the same products, indicating that the
proteasomal cleavage specificity was not altered upon infection. These data
indicate that infection of lymphoid cells by S. typhimurium fails to induce
formation of immunoproteasomes or otherwise alter the proteolytic speci-
ficity of the 20S proteasome.
Keywords: antigens; arthritis; peptides; proteasome; Salmonella
Abbreviations: C1R, HMy2.C1R; CFU, colony-forming units; CTL, cytotoxic T lymphocyte; DMEM, Dulbecco’s modified Eagle’s
medium; FCS, fetal calf serum; IEF, isoelectrofocusing; IFN-c, interferon-c; IPG, immobilized pH gradient; LB, Luria–Bertani
medium; LPS, lipopolysaccharide; mAb, monoclonal antibody; MALDI-TOF, matrix-assisted laser desorption/ionization time of
flight; MHC, major histocompatibility complex; MS, mass spectrometry; PBS, phosphate-buffered saline; ReA, reactive arthritis.
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rings. The external rings consist of seven structural
subunits (a1 to a7). The internal rings consist of seven b
subunits (b1 to b7) of which three are catalytic: b1, b2
and b5. These can be substituted for three interferon-c
(IFN-c)-induced subunits: b1i, b2i and b5i, in an appar-
ently cooperative process.13,14 Thus, there is a constitutive
proteasome, containing the b1, b2 and b5 subunits, and
an immunoproteasome, containing the corresponding
IFN-c-induced subunits.
It has been reported that infection of HeLa cells by
S. typhimurium results in an increase of the inducible
subunit b1i, and concomitant changes in the HLA-B27-
bound peptide repertoire.15 Changes in the B27-bound
peptide repertoire were also reported in L cells infected
with Shigella flexneri.16 In contrast, in the lymphoid cell
line C1R, the HLA-B27-bound peptide repertoires from
S. typhimurium-infected and non-infected cells are very
similar.1,17,18 Nevertheless, B27-restricted bacteria-specific
CTLs isolated from synovial fluid of ReA patients killed
Salmonella-infected HLA-B27-C1R targets,19 suggesting
that small amounts of bacterial peptides were presented
by HLA-B27 on these cells.
The question remained as to whether infection of lym-
phoid cells with S. typhimurium might also promote the
induction of immunoproteasomes, leading to the modula-
tion of antigen processing and HLA-B27-mediated pep-
tide presentation. Thus, in the present work we analysed
whether infection of C1R cells with S. typhimurium affects
the subunit composition or activity of 20S proteasomes.
Materials and methods
Cell lines, bacteria and antibodies
HMy2.C1R (C1R) is a human lymphoid cell line with low
expression of its endogenous class I molecules.20,21 The
transfectant cell line expressing B*2705 has been previ-
ously described.22 Cells were cultured in Dulbecco’s
modified Eagles’s medium (DMEM) supplemented with
75% heat-inactivated fetal calf serum (FCS) (both from
Life Technologies, Paisley, UK). SL1344 is a virulent Sal-
monella serovar typhimurium strain.23 It was cultured
overnight in Luria-Bertani (LB) medium without shaking.
Human recombinant IFN-c was obtained from Calbio-
chem (Darmstadt, Germany).
The following antibodies were used: the monoclonal
antibody (mAb) W6/32 [immunoglobulin G2a (IgG2a),
specific for a monomorphic HLA-A, -B, -C determin-
ant],24 a polyclonal antiserum specific for the S. typhimu-
rium lipopolysaccharide (LPS) (Difco, Detroit, MI), the
polyclonal antibody 8016.2, which recognizes the protea-
some subunit a6,
25 the polyclonal antibody 8026.3, which
recognizes the IFN-c-induced subunit b1i, and cross-
reacts with b5i, and the polyclonal antibody 8027.3, which
recognizes the IFN-c-induced subunit b5i. Both of these
antibodies were produced by injection of the purified
recombinant proteins into rabbits, as previously des-
cribed.25 Antibodies PW.8840 and PW.8140, which recog-
nize the proteasome subunits b1i and b1, respectively,
were supplied by Affiniti (Mamhead, Exeter, UK).
PW.8840 recognizes both the mature b1i subunit at
22 000 molecular weight (MW) and the 25 000 MW pre-
cursor form. The anti-b-actin mAb A.5316 was obtained
from Sigma-Aldrich (St. Louis, MO).
Infection of B*2705-C1R cells with S. typhimurium
Large-scale infections were performed as previously des-
cribed.1 Briefly, About 3 · 109 cells were grown in roller
flasks, centrifuged for 10 min at 500 g and resuspended in
750 ml RPMI-1640 with 10% FCS. Bacteria (about 1011)
were centrifuged and resuspended in 10 ml of the same
medium, and added to the cells. Cells were mixed with
bacteria and incubated at 37 for 2 hr. Then, cells were
washed four times in phosphate-buffered saline (PBS) sup-
plemented with 100 lg/ml gentamicin to eliminate extra-
cellular bacteria, and incubated in DMEM with 5% FCS
for 24 hr. Finally, cells were washed four times in PBS, and
frozen at )80 until their use for proteasome purification.
Alternatively, after washing, aliquots were taken to quantify
the intracellular bacteria as colony-forming units (CFU)
and to analyse the percentage of infected cells by immuno-
fluorescence. The intracellular location of bacteria was con-
firmed by confocal and electron microscopy.1
Immunofluorescence of infected cells
Cover slips were overlaid with 1 mg/ml poly L-lysine
(Sigma, St Louis, MO) for 30 min and washed three
times with PBS. Infected cells were placed on cover slips,
incubated for 30 min at room temperature and washed
three times with PBS. Adhered cells were fixed with 35%
paraformaldehyde (Merck, Darmstadt, Germany) in PBS
for 20 min, and washed three times with PBS. Thirty-five
microlitres 3% bovine serum albumin in PBS containing
01% saponin (both from Sigma) was added to cover
slips, incubated for 5 min, and then incubated in 35 ll of
a 1 : 200 dilution of rabbit anti-S. typhimurium LPS anti-
serum for 45 min. After this time, cells were blocked
again with bovine serum albumin, and incubated with a
1 : 50 dilution of fluorescein-isothiocyanate-conjugated
goat anti-rabbit IgG (Cooper Biomedical, Malvern, PA)
for 45 min. After washing, cover slips were placed over
Mowiol-treated slides and incubated for 1 hr at 37.
Purification of 20S proteasomes
Proteasomes were purified from about 3 · 109 B*2705-
C1R cells as previously described9,26,27 with modifications.
Briefly, cells were potter-lysed in 50 mM Tris-HCl, 25 mM
132  2007 Blackwell Publishing Ltd, Immunology, 122, 131–139
M. Marcilla et al.
KCl, pH 80, centrifuged to 1500 g for 10 min and then
ultracentrifuged for 1 hr at 100 000 g. The supernatant
was loaded on a 35-ml diethylaminoethyl-cellulose
(DE52) anion exchange column (Whatman, Maidstone,
UK) equilibrated with buffer A (50 mM Tris-HCl, 25 mM
KCl, pH 80). After washing the column with three vol-
umes of equilibration buffer, elution was carried out with
buffer B (50 mM Tris-HCl, 03 M KCl, pH 8). Protein-
containing fractions were detected using the Bradford
method, diluted three times in buffer A, concentrated in
a 7-ml DE52 column equilibrated with the same buffer,
washed with three volumes of the buffer, and eluted in
buffer B. Protein-containing fractions were loaded onto a
gradient of 10–30% glycerol in 50 mM Tris-HCl, 25 mM
KCl, 1 M urea, pH 80, and centrifuged for 18 hr at
200 000 g. Five-drop fractions were taken, and analysed
by a 12% sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE). Proteasome-containing frac-
tions were pooled, and subjected to anion-exchange chro-
matography in a monoQ SR5/5 column (Pharmacia,
Uppsala, Sweden) at a flow rate of 05 ml/min, as follows:
isocratic conditions with buffer A (50 mM Tris-HCl,
50 mM KCl, pH 80) for 10 min, followed by a linear gra-
dient of 0–30% buffer B (50 mM Tris-HCl, 05 M KCl
pH 80) for 5 min, and a linear gradient of 30–100% buf-
fer B for another 30 min. Purity of fractions was assessed
by SDS-PAGE and staining with Coomassie blue or silver.
Aliquots were stored at )80.
Western blot analysis
About 2 lg purified 20S proteasomes from non-infected
and infected cells (24 hr postinfection time) were loaded
in 12% SDS-PAGE gels. Proteins were transferred to
polyvinylidene difluoride membranes. These were blocked
for 30 min with 5% skimmed milk in 01% Tween-20 in
PBS (T-PBS). b1i and b5i subunits were detected with the
polyclonal antibodies 8026.3 and 8027.3, respectively. Sec-
ond antibody was a horseradish peroxidase-labelled goat
anti-rabbit. Detection was performed using ECLTM (both
from Amersham).
In other experiments B*2705-C1R cells were grown in
the presence or absence of IFN-c (100 U/ml) for 24 hr.
About 106 cells were boiled in SDS-PAGE loading buffer
for 10 min and loaded in 12% SDS-PAGE gels. Proteins
were transferred to nitrocellulose membranes. These were
blocked for 60 min with 5% skimmed milk in T-PBS.
b1i and b1 were detected with monoclonal antibodies
PW.8840 and PW.8140, respectively, and with secondary
antibody as above.
Two-dimensional gel electrophoresis of 20S proteasomes
Samples of purified 20S proteasomes from S. typhimu-
rium-infected and control cells were loaded by hydration
of immobilized pH gradient strips (IPG), non-linear
pH 3–10, 18 cm in length (Pharmacia, Uppsala, Sweden),
diluted previously up to a total volume of 350 ll in 6 M
urea, 2 M thiourea, 2% CHAPS, ampholineTM pH 3–10,
1 mM tris-[2-carboxymethyl]-phosphine-HCl, and 01%
bromophenol blue. In the first dimension, isoelectrofocus-
ing (IEF) was performed in a IPGPhor (Pharmacia) under
the following conditions: 30 V for 6 hr, 60 V for 6 hr,
500 V for 30 min, 1000 V for 30 min, a gradient of 1000–
8000 V for 30 min, and 8000 V up to 32 000 Vh. After
IEF, strips were equilibrated in 6 M urea, 30% glycerol, 2%
SDS, and 01% bromophenol blue, twice for 20 min.
Dithiothreitol (2%), and 4% iodoacetamide were added in
the first and second equilibration steps, respectively. The
second dimension was performed using 125% SDS-PAGE.
Gels were stained with silver nitrate, scanned and analysed
using the software IMAGEMASTER (Pharmacia).
In-gel digestion of proteins
Protein spots were cut manually and processed automat-
ically in a digestor InvestigatorTM ProGest (Genomic
Solutions, Cambridgeshire, UK). Samples were washed
with 25 mM ammonium bicarbonate and then with 100%
acetonitrile, reduced with 10 mM dithiothreitol in 25 mM
ammonium bicarbonate, alkylated with 100 mM iodoacet-
amide in 50 mM ammonium bicarbonate, washed in
50 mM ammonium bicarbonate and then with 100%
acetonitrile, and dried with nitrogen. Modified pig trypsin
(Promega, Madison, WI) was added to dried samples to a
final concentration of 16 ng/ll in 25 mM ammonium
bicarbonate and digested for 12 hr at 37. Peptides were
eluted with 100 ll 33% acetonitrile, 25 mM ammonium
bicarbonate and 10% formic acid, and subjected to
matrix-assisted laser desorption/ionization time of flight
(MALDI-TOF) mass spectrometry (MS) fingerprinting
analysis to identify each proteasome subunit.
Digestion of oxidized insulin B-chain
Ten micrograms of oxidized insulin B-chain (Sigma) was
digested with 1 lg purified 20S proteasome for 24 hr at
37. Digestion was stopped with trifluoroacetic acid 01%
in water. Digestion products were fractionated as des-
cribed elsewhere.8
Mass spectrometry
The MALDI-TOF MS analysis of proteasomal digestions
was performed using a calibrated Reflex (Brucker Dalton-
ics, Bremen, Germany) operating in positive ion reflec-
tron mode as previously described.9 When necessary
peptides were sequenced in an electrospray/ion trap mass
spectrometer (Finnigan Thermoquest, San Jose´, CA), as
previously described.28,29
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Results
C1R cells express a mixture of constitutive
proteasome and immunoproteasome
The subunit composition of 20S proteasome purified
from B*2705-C1R cells was analysed by two-dimensional
gel electrophoresis, and each subunit was identified by
MS fingerprinting (Fig. 1a). In this analysis, both the con-
stitutive proteasome subunits (b1, b2 and b5) and, in
lower amounts, the corresponding inducible ones (b1i, b2i
and b5i) were observed. Thus, C1R cells express a mixture
of constitutive proteasome and immunoproteasome, but
the former is more abundant.
Infection with S. typhimurium does not change the
composition of the 20S proteasome in lymphoid cells
To study the effects of Salmonella infection on the com-
position of 20S proteasomes, B*2705-C1R cells were
infected with S. typhimurium with a postinfection time of
24 hr. C1R cells were used for two reasons: first, because
this is a cell line that grows well in suspension, and it is
possible to infect several billion cells, which are required
for purification of the 20S proteasome. Second because
the infection of C1R cells with Salmonella induces some
changes in the HLA-B27-bound peptide repertoire that
are recognized by T cells.19
We chose the SL1344 strain because it is perhaps the
most extensively used serovar typhimurium strain for
in vivo and in vitro infections. Although it is a His-negat-
ive strain, assays performed in epithelial and macrophage
cell lines have shown that histidine auxotrophy does not
affect proliferation of this particular strain inside these
cells. Bacteria were grown in an overnight non-shaking
culture to obtain highly motile and fully infective bac-
teria. Quantification of intracellular bacteria was per-
formed measuring the CFU recovered after cell lysis with
Triton X-100. The percentage of infected cells was estima-
ted by immunofluorescence with an antiserum recogni-
zing the Salmonella LPS. About 50% of the cells were
infected, with a mean number of two intracellular bac-
teria per cell.
The 20S proteasomes from infected and non-infected
B*2705-C1R cells were purified, and analysed by two-
dimensional gel electrophoresis and MS fingerprinting.
This analysis showed no significant difference in the 20S
proteasome composition between non-infected and infec-
ted cells (Fig. 1). In addition, Western blot analysis using
anti-b1i and anti-b5i antibodies did not show any change
in the expression of these components between the pro-
teasomes from non-infected and 24 hr-infected cells
(Fig. 2a). The absence of immunoproteasome induction
was not the result of an intrinsic inability of C1R cells to
modulate the inducible subunits at this postinfection
time, because the induction with IFN-c for 24 hr pro-
duced an increase of b1i detectable by Western blot
(Fig. 2b). These results indicate that S. typhimurium
infection does not induce any significant changes in the
proteasome/immunoproteasome ratio in the human lym-
phoid cells tested.
The chromatographic profiles of the digestion
products of insulin B chain with 20S proteasome
from Salmonella-infected and non-infected cells
are indistinguishable
Digestions of oxidized insulin B chain have been previ-
ously used to establish the specificity differences between
constitutive proteasomes and immunoproteasomes.30
Thus, 10 lg insulin B chain were digested with purified
20S proteasomes from non-infected and Salmonella-infec-
ted B*2705-C1R cells. These were infected and cultured
for 24 hr after infection. About three bacteria per cell
were counted, and the percentage of infected cells was
about 50%.
Digestion products were fractionated by high-perform-
ance liquid chromatography (HPLC). The corresponding
chromatographic profiles were very similar (Fig. 3). A
small peak was found in the chromatogram of infected
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Figure 1. Two-dimensional gels of 20S protea-
somes from non-infected (a) and S. typhimu-
rium-infected (b) B27-C1R lymphoid cells.
Proteasome purifications were performed as
described in the Materials and methods. About
10 lg of proteasome were analysed by two-
dimensional electrophoresis, and identification
of spots were performed by mass spectrometry
after trypsin digestion as described in the
Materials and methods.
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cells around a retention time of 49 min, which was not
present in the control, but the corresponding HPLC frac-
tion did not show any ion peak upon MALDI-TOF analy-
sis (see below). Thus, the HPLC profiles of the digestion
products failed to reveal any significant difference in the
specificity of the 20S proteasomes following infection with
S. typhimurium. Furthermore, no differences were found
when a precursor peptide spanning residues 120/146 of
the proteasome C5 subunit9 was digested with 20S pro-
teasome from non-infected and infected cells (data not
shown).
Insulin B chain digestion with 20S proteasome from
Salmonella-infected and non-infected cells generates
the same peptide products
Although the HPLC chromatograms of products obtained
in digestions of insulin B chain with proteasomes from
non-infected and infected C1R cells were very similar, this
did not rule out the possibility that differentially produced
peptides could be concealed in HPLC peaks containing
multiple coeluting peptides. To test this possibility, a sys-
tematic analysis of the HPLC fractions corresponding to
absorbance peaks was carried out by MALDI-TOF MS.
When necessary, individual peptides were sequenced by
quadrupole ion trap nanoelectrospray MS/MS. To quan-
tify the yield of an individual peptide, the absorbance at
210 nm of the corresponding HPLC peak was considered,
and was normalized to take into account peptidic length
differences. When several peptides coeluted, the percentage
of each peptide in the absorbance peak was estimated on
the basis of their respective ion peak signal intensities in
the MALDI-TOF spectra. This is only an approximation,
because ion peak intensity does not necessarily correlate
with peptide abundance. When a peptide eluted in more
than one fraction, its total estimated abundance in all the
fractions was considered.
Many peptide bonds were hydrolysed at 24 hr digestion
time. Figure 4 is a schematic representation of the pep-
tides generated, and their estimated yields are shown in
Table 1. The major cleavage sites were after Gln4, His5,
Leu6, Glu13, Leu15, Leu17, Cys19 and Phe24. Various
β1i
β5i
β5i
β1i
Non-Inf. Inf.
0 hr 24 hr
Non-Inf.(a)
(b)
Inf.
β5i
β1i (precursor)
β-Actin
β1i (mature)
Figure 2. Western blot analysis of proteasome subunits. (a) Western
blot analysis of inducible b-subunits of the 20S proteasome from
B27-C1R cells. About 2 lg purified 20S proteasomes from non-infec-
ted and infected (24 hr postinfection time) B27-C1R cells were sub-
jected to 12% SDS-PAGE. Proteins were transferred to membranes,
and analysed by Western blot. Upper panel: Western blot using the
polyclonal antibody 8026.3, which recognizes the inducible subunit
b1i, and cross-reacts with b5i. The intensity ratio of the b1i and the
cross-reactive b5i bands between infected (Inf.) and non-infected
(Non-Inf.) cells were 096 : 1 and 136 : 1, respectively. Lower panel:
Western blot using the polyclonal antibody 8027.3, which recognizes
the inducible subunit b5i. The intensity ratio of the bands corres-
ponding to Inf. and Non-Inf. cells was 103 : 1. (b) Western blot
analysis of constitutive (b1) and inducible (b1i) subunits in control
and IFN-c-induced C1R-05 cells. About 106 cells were lysed in SDS-
PAGE loading buffer and subjected to 12% SDS-PAGE. Constitutive
and induced subunits were detected as described in the Materials
and methods. b-actin was used as a housekeeping protein. The
intensity of the b1i bands, after IFN-c stimulation was increased
284-fold, relative to non-stimulated cells, after normalizing to the
intensity of the corresponding actin bands.
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Figure 3. HPLC chromatography of digestion products from oxid-
ized insulin B chain with 20S proteasomes. About 10 lg substrate
were digested with 1 lg purified 20S proteasomes from non-infected
and S. typhimurium-infected B27-C1R cells for 24 hr at 37. Diges-
tion mixtures were fractionated by HPLC.
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other bonds were cleaved less efficiently (Table 1). Clea-
vage efficiency at nearly all cleavage sites was very similar
with 20S proteasome from infected or non-infected cells,
except for a few of the peptide bonds cleaved with low
efficiency (Table 1).
These results indicate that S. typhimurium infection of
B*2705-C1R cells does not affect the specificity of the 20S
proteasome after 24 hr infection. This is consistent with
the lack of changes in subunit composition of the 20S
proteasome observed at the same postinfection time.
Discussion
Although lymphoid cells are not the physiological target
of S. typhimurium they were used in this study for two
reasons. First, because the overwhelming majority of stud-
ies on HLA-B27-bound peptides have been carried out
with these cells. Second, and more important, because
lymphoid cells infected with S. typhimurium can be recog-
nized by HLA-B27-restricted bacteria-specific CTLs as
early as 4 hr after infection,19 implying that bacterial pep-
tides have been processed and presented by HLA-B27 on
the cell surface. The amount of bacterial antigen, although
sufficient for CTL recognition, is presumably quite small
because MS analysis of the HLA-B27-bound peptide
repertoire failed to reveal virtually any peptide differen-
tially expressed on infected cells.1,17,18 The nature of HLA-
B27-restricted bacterial peptides that are relevant to the
CTL response in patients with Salmonella-induced ReA
remains unknown. Any putative alterations in the HLA
class I antigen processing pathway following intracellular
infection by S. typhimurium could influence the presenta-
tion of both the bacterial peptide antigens and of some of
the endogenous HLA-B27 self-ligands. In this study we
specifically asked whether Salmonella infection of lym-
phoid cells might influence the structure and/or the activ-
ity of the 20S proteasome at infection times sufficient for
antigen presentation to occur. The C1R cell line used in
our study contained a mixture of constitutive proteasome
and immunoproteasome, in which the former was pre-
dominant. This pattern was not altered even at 24 hr after
infection, as estimated by two-dimensional gel electro-
phoresis and Western blot analysis. These experiments do
not rule out the possibility that a very small induction of
immunoproteasome subunits might occur, but argue
Non-infected
Infected
Figure 4. Digestion pattern of oxidized insulin B chain by purified
20S proteasomes from non-infected and infected cells. About 10 lg
substrate was digested with 1 lg proteasomes for 24 hr at 37. Diges-
tion mixtures were fractionated by HPLC, and absorbance peaks
were analysed by MALDI-TOF or electrospray ion trap mass spectro-
metry. Thick, medium and thin lines correspond to peptides recov-
ered at > 4%, 1–4% and < 1% yield of the total digest, respectively.
Only peptides recovered with  02% yield are indicated. Thick,
medium and thin arrows indicate cleavage sites that generated pep-
tides with total yields > 5%, 1–5% and < 1% of the total digest,
respectively. Peptides labelled with asterisks were found with an
amount less than the 02% of the total of digest, but were included
because in the counterpart they were recovered at  02%.
Table 1. Proteasomal cleavage of insulin oxidized B chain1
Cleavage
after
Non-infected
yield (%)
Infected yield
(%)
Ratio
non-infected :
infected
Phe1 Not observed Not observed –
Val2 Not observed Not observed –
Asn3 Not observed Not observed –
Gln4 313 242 13
His5 70 100 07
Leu6 112 110 10
Cys7 01 02 05
Gly8 Not observed Not observed –
Ser9 02 03 07
His10 01 01 10
Leu11 08 09 09
Val12 Not observed Not observed –
Glu13 168 151 11
Ala14 15 16 09
Leu15 57 42 14
Tyr16 Not observed Not observed –
Leu17 107 99 11
Val18 36 42 09
Cys19 84 90 09
Gly20 04 06 07
Glu21 01 02 05
Arg22 Not observed Not observed –
Gly23 01 Not observed –
Phe24 54 62 09
Phe25 Not observed 01 –
Tyr26 28 24 12
Thr27 01 Not observed –
Pro28 02 01 2
Lys29 11 10 11
1Cleavage yield at a peptide bond was estimated as the total percent-
age of peptides in the digestion mixture resulting from cleavage at
that bond.
136  2007 Blackwell Publishing Ltd, Immunology, 122, 131–139
M. Marcilla et al.
against any significant changes in the proteasome/immuno-
proteasome balance occurring upon infection.
These results are in contrast with a previous report15
in which infection of HeLa cells with S. typhimurium
increased the reverse transcription-polymerase chain reac-
tion values of the b1i, b2i and b5i subunits, and the
amount of b1i protein as detected by Western blot analy-
sis, although in that study the expected changes in the
mature proteasomes purified from infected cells were not
analysed. These differences might be attributed to the
different cell lines used in both studies, and to the differ-
ent behaviour of the bacteria in both cell types, because
S. typhimurium proliferates inside HeLa cells, but not, or
very little, inside C1R cells.
The cleavage specificity of the 20S proteasome, as
assessed with a synthetic substrate previously used in
proteasome activity studies,30-32 was not altered 24 hr
after infection. These results suggest that bacterial antigen
presentation in lymphoid cells occurs without any signifi-
cant changes of the 20S proteasome following Salmonella
infection. Absence of proteasomal changes also suggests
that the proteasome-mediated processing of endogenous
self-proteins should not be significantly altered. This is in
agreement with previous reports indicating that intra-
cellular Salmonella infection does not change the B27-
bound peptide repertoires in lymphoid cells.1,17,18 It can
be argued that a postinfection time of 24 hr might be
too short to allow for a significant increase of immuno-
proteasome levels, but we were interested in knowing
whether such changes can be detectable at times in which
HLA-B27-restricted bacterial antigen presentation is
known to take place. In C1R cells a postinfection time of
4 hr was enough to make infected cells a target for bac-
teria-specific CTLs.1 Furthermore, C1R cells were able to
induce the immunoproteasome subunit b1i after incuba-
tion for 24 hr with IFN-c, indicating the ability of this
cell line to modulate the proteasome subunit composi-
tion at the postinfection times used in this study.
The class I antigen-processing pathway is complex, with
various steps that together determine the presentation of
any given ligand, including the generation of the ligand
or N-terminally extended precursors of the proteasome,
transport to the endoplasmic reticulum through trans-
porter associated with antigen processing (TAP) and
amino-peptidase-mediated trimming inside the lumen of
endoplasmic reticulum.9 In this work we analysed the
influence of Salmonella infection on the composition and
activity of the 20S proteasome. In addition, although spe-
cific T-cell responses against Salmonella-infected C1R cells
have been described even at a postinfection time of
4 hr,19 we increased the postinfection time to 24 hr. Even
so, our data indicate that, although the effects produced
by salmonella infection on B cells are enough for a speci-
fic T-cell response, the corresponding epitopes could not
be detected using biochemical techniques. Together, our
results indicate that infection of lymphoid cells with the
arthritogenic bacterium S. typhimurium affects neither the
composition nor the specificity of the 20S proteasome at
infection times long enough for HLA class I-mediated
antigen presentation, and suggest that changes in the gen-
eration of antigenic peptides based on modification of the
proteasome are unlikely.
The percentage of infected cells was about 50% after a
postinfection time of 24 hr. Thus, we cannot rule out that
minor differences in the composition or activity of the
20S proteasome might be overlooked in our analysis.
Nevertheless, our data suggest that Salmonella infection
might induce minor changes in the B27-bound peptide
repertoire but not a significant alteration of proteasome
mediated processing.
The nature of the bacterial peptides presented by HLA-
B27 after Salmonella infection and their processing is
unknown. A limited number of bacterial proteins are
injected into the cytosol through the type III secretion
system33-35 and are degraded by the proteasome.36 Whe-
ther other bacterial proteins or peptides reach the class I
processing-loading pathway is still unclear.
Our results concern only lymphoid cells and cannot
be readily generalized to other cell types, such as macro-
phages or dendritic cells. However, the fact that CTL
from Salmonella-induced ReA patients recognize infected
C1R cells19 strongly suggests that the bacterial antigens
eliciting the HLA-B27-restricted CTL response in vivo are
the same as those presented by HLA-B27 on infected lym-
phoid cells.
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